2
|
Filipski KJ, Guzman-Perez A, Bian J, Perreault C, Aspnes GE, Didiuk MT, Dow RL, Hank RF, Jones CS, Maguire RJ, Tu M, Zeng D, Liu S, Knafels JD, Litchfield J, Atkinson K, Derksen DR, Bourbonais F, Gajiwala KS, Hickey M, Johnson TO, Humphries PS, Pfefferkorn JA. Pyrimidone-based series of glucokinase activators with alternative donor–acceptor motif. Bioorg Med Chem Lett 2013; 23:4571-8. [DOI: 10.1016/j.bmcl.2013.06.036] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2013] [Revised: 06/07/2013] [Accepted: 06/11/2013] [Indexed: 10/26/2022]
|
3
|
Guzman-Perez A, Pfefferkorn JA, Lee EC, Stevens BD, Aspnes GE, Bian J, Didiuk MT, Filipski KJ, Moore D, Perreault C, Sammons MF, Tu M, Brown J, Atkinson K, Litchfield J, Tan B, Samas B, Zavadoski WJ, Salatto CT, Treadway J. The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitus. Bioorg Med Chem Lett 2013; 23:3051-8. [DOI: 10.1016/j.bmcl.2013.03.014] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2013] [Revised: 02/26/2013] [Accepted: 03/04/2013] [Indexed: 10/27/2022]
|
4
|
Filipski KJ, Bian J, Ebner DC, Lee EC, Li JC, Sammons MF, Wright SW, Stevens BD, Didiuk MT, Tu M, Perreault C, Brown J, Atkinson K, Tan B, Salatto CT, Litchfield J, Pfefferkorn JA, Guzman-Perez A. A novel series of glucagon receptor antagonists with reduced molecular weight and lipophilicity. Bioorg Med Chem Lett 2012; 22:415-20. [DOI: 10.1016/j.bmcl.2011.10.113] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2011] [Revised: 10/25/2011] [Accepted: 10/31/2011] [Indexed: 11/25/2022]
|
5
|
Kalgutkar AS, Griffith DA, Ryder T, Sun H, Miao Z, Bauman JN, Didiuk MT, Frederick KS, Zhao SX, Prakash C, Soglia JR, Bagley SW, Bechle BM, Kelley RM, Dirico K, Zawistoski M, Li J, Oliver R, Guzman-Perez A, Liu KKC, Walker DP, Benbow JW, Morris J. Discovery Tactics To Mitigate Toxicity Risks Due to Reactive Metabolite Formation with 2-(2-Hydroxyaryl)-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one Derivatives, Potent Calcium-Sensing Receptor Antagonists and Clinical Candidate(s) for the Treatment of Osteoporosis. Chem Res Toxicol 2010; 23:1115-26. [DOI: 10.1021/tx100137n] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Amit S. Kalgutkar
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - David A. Griffith
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Tim Ryder
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Hao Sun
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Zhuang Miao
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Jonathan N. Bauman
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Mary T. Didiuk
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Kosea S. Frederick
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Sabrina X. Zhao
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Chandra Prakash
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - John R. Soglia
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Scott W. Bagley
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Bruce M. Bechle
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Ryan M. Kelley
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Kenneth Dirico
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Michael Zawistoski
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Jianke Li
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Robert Oliver
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Angel Guzman-Perez
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Kevin K. C. Liu
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Daniel P. Walker
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - John W. Benbow
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| | - Joel Morris
- Pharmacokinetics, Dynamics and Metabolism Department and Department of Medicinal Chemistry, Pfizer Global Research and Development, Groton, Connecticut 06340
| |
Collapse
|
11
|
Gierasch TM, Chytil M, Didiuk MT, Park JY, Urban JJ, Nolan SP, Verdine GL. A modular synthetic approach toward exhaustively stereodiversified ligand libraries. Org Lett 2000; 2:3999-4002. [PMID: 11112627 DOI: 10.1021/ol006560k] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
[structure] This report describes a modular approach to the synthesis of stereodiversified natural product-like libraries. Monomers 2 and 3 were coupled in parallel by silyl-tethered olefin metathesis to generate all 16 stereoisomers of cis-enediols 1. All 16 stereoisomers were incorporated into chimerae having flanking peptidic segments. These chimerae exhibited a broad range of hydrophobicities, raising the possibility that stereochemical variation might be used to tune the pharmacologic properties of small molecules.
Collapse
Affiliation(s)
- T M Gierasch
- Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, USA
| | | | | | | | | | | | | |
Collapse
|
12
|
Abstract
Abstract:
A large variety of metal-based chiral complexes have been developed in the past twenty five years that allow for the effective catalytic resolution of an impressive range of racemic compounds. After the initial discovery of Ti-catalyzed kinetic resolution of allylic alcohols by Sharpless and coworkers in the early eighties, a number of other transformations have emerged that may be used for catalytic resolution. Amongst them are the Ru-catalyzed hydrogenation, the Zr-catalyzed carbomagnesation, the Mn-catalyzed epoxidation, the Co-catalyzed epoxide hydrolysis, and the Ti-catalyzed reduction of C=N and C=0 bonds. Most recently, the Mo-catalyzed ring-closing metathesis has been utilized to catalytically resolve organic molecules in an efficient manner. This article provides a brief overview of these and other major developments in metal-catalyzed kinetic resolution; strengths and weaknesses of various methods are discussed, and different protocols that afford identical or similar optically pure or enriched compounds are compared. Where possible, the available mechanistic paradigms that affords a rationale as to the observed stereochemical outcomes are provided.
Collapse
Affiliation(s)
- Amir H. Hoveyda
- Merkert Chemistry Center, Department of Chemistry, Boston College, Chestnut Hill, Massachusetts 02467, USA
| | - Mary T. Didiuk
- Merkert Chemistry Center, Department of Chemistry, Boston College, Chestnut Hill, Massachusetts 02467, USA
| |
Collapse
|
13
|
Gomez-Bengoa E, Heron NM, Didiuk MT, Luchaco CA, Hoveyda AH. Ni-Catalyzed Asymmetric Addition of Grignard Reagents to Unsaturated Cyclic Acetals. The Influence of Added Phosphine on Enantioselectivity. J Am Chem Soc 1998. [DOI: 10.1021/ja980499l] [Citation(s) in RCA: 75] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Enrique Gomez-Bengoa
- Department of Chemistry, Merkert Chemistry Center Boston College, Chestnut Hill, Massachusetts 02167
| | - Nicola M. Heron
- Department of Chemistry, Merkert Chemistry Center Boston College, Chestnut Hill, Massachusetts 02167
| | - Mary T. Didiuk
- Department of Chemistry, Merkert Chemistry Center Boston College, Chestnut Hill, Massachusetts 02167
| | - Courtney A. Luchaco
- Department of Chemistry, Merkert Chemistry Center Boston College, Chestnut Hill, Massachusetts 02167
| | - Amir H. Hoveyda
- Department of Chemistry, Merkert Chemistry Center Boston College, Chestnut Hill, Massachusetts 02167
| |
Collapse
|
15
|
Visser MS, Heron NM, Didiuk MT, Sagal JF, Hoveyda AH. Catalytic and Enantioselective Route to Medium-Ring Heterocycles. Asymmetric Zirconium-Catalyzed Ethylmagnesation of Seven- and Eight-Membered Rings. J Am Chem Soc 1996. [DOI: 10.1021/ja960163g] [Citation(s) in RCA: 83] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Michael S. Visser
- Contribution from the Department of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02167
| | - Nicola M. Heron
- Contribution from the Department of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02167
| | - Mary T. Didiuk
- Contribution from the Department of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02167
| | - John F. Sagal
- Contribution from the Department of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02167
| | - Amir H. Hoveyda
- Contribution from the Department of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02167
| |
Collapse
|